The Implication of Short-Chain Fatty Acids in Obesity and Diabetes

Evidence indicates that short-chain fatty acids (SCFAs) generated from the gut microbiota play crucial roles in host metabolism. They contribute to metabolic regulation and energy acquisition of the host by influencing the development of metabolic disorders. This review aims to synthesize recent advances from the literature to investigate the implication of SCFAs in the modulation of obesity and diabetes pathologies. For a better understanding of the relationships between SCFAs and host metabolism, we need to answer some questions: What is the biochemistry of SCFAs, and how they are generated by gut microbiota? What are the bacteria producing of SCFAs and from which routes? How SCFAs are absorbed and transported in the gut by different mechanisms and receptors? How SCFAs involved in obesity and diabetes pathologies?

[1]  E. Blaak,et al.  Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use , 2022, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2]  T. Hansen,et al.  Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial , 2022, Journal of clinical medicine.

[3]  Yingying Han,et al.  Seasonal expressions of GPR41 and GPR43 in the colon of the wild ground squirrels (Spermophilus dauricus) , 2022, European journal of histochemistry : EJH.

[4]  Connor T. Skennerton,et al.  Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes , 2022, BMC microbiology.

[5]  Y. Meng,et al.  The bioavailability of soy isoflavones in vitro and their effects on gut microbiota in the simulator of the human intestinal microbial ecosystem. , 2021, Food research international.

[6]  G. Mithieux,et al.  Intestinal gluconeogenesis shapes gut microbiota, fecal and urine metabolome in mice with gastric bypass surgery , 2021, Scientific Reports.

[7]  M. Ricote,et al.  The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders , 2021, International Journal of Molecular Sciences.

[8]  Qin Liu,et al.  Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome , 2021, Frontiers in Cellular and Infection Microbiology.

[9]  F. Chegdani,et al.  Breastfeeding and the Influence of the Breast Milk Microbiota on Infant Health , 2021, Neonatal Intensive Care Unit [Working Title].

[10]  C. Pollock,et al.  The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease , 2021, International journal of molecular sciences.

[11]  Yulong Yin,et al.  From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators , 2021, Microbiome.

[12]  L. Johnston,et al.  Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease , 2021, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[13]  R. del Campo,et al.  Taxonomic Characterization and Short-Chain Fatty Acids Production of the Obese Microbiota , 2021, Frontiers in Cellular and Infection Microbiology.

[14]  J. Wells,et al.  Microbial Regulation of Host Physiology by Short-chain Fatty Acids. , 2021, Trends in microbiology.

[15]  J. Ferguson,et al.  Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension , 2021, Current Hypertension Reports.

[16]  R. Berni Canani,et al.  The Protective Role of Butyrate against Obesity and Obesity-Related Diseases , 2021, Molecules.

[17]  Yulong Yin,et al.  Butyrate in Energy Metabolism: There Is Still More to Learn , 2021, Trends in Endocrinology & Metabolism.

[18]  Yanbing Wang,et al.  The role of Short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. , 2021, Pharmacological research.

[19]  Yi Li,et al.  Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer’s disease and their potential links in the pathogenesis , 2021, Gut microbes.

[20]  A. Valdes,et al.  The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health , 2021, Gut microbes.

[21]  A. A. Farooqui.  Importance of fiber in human diet: Contribution of microbiota in human health , 2021 .

[22]  L. Johnston,et al.  Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation , 2020, Medicinal research reviews.

[23]  T. J. Ashaolu,et al.  Fermentation of prebiotics by human colonic microbiota in vitro and short‐chain fatty acids production: a critical review , 2020, Journal of applied microbiology.

[24]  L. Niu,et al.  Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism , 2020, International journal of molecular sciences.

[25]  C. Edwards,et al.  Impact of the source of fermentable carbohydrate on SCFA production by human gut microbiota in vitro - a systematic scoping review and secondary analysis , 2020, Critical reviews in food science and nutrition.

[26]  K. Verbeke,et al.  Short chain fatty acids in human gut and metabolic health. , 2020, Beneficial microbes.

[27]  T. J. Ashaolu.  Immune boosting functional foods and their mechanisms: A critical evaluation of probiotics and prebiotics. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  M. Akhlaghi,et al.  Effect of short- and long-term protein consumption on appetite and appetite-regulating gastrointestinal hormones, a systematic review and meta-analysis of randomized controlled trials , 2020, Physiology & Behavior.

[29]  C. Akdis,et al.  Initial butyrate producers during infant gut microbiota development are endospore formers. , 2020, Environmental microbiology.

[30]  Baoguo Sun,et al.  Dynamic balancing of intestinal short-chain fatty acids: The crucial role of bacterial metabolism , 2020, Trends in Food Science & Technology.

[31]  L. Johnston,et al.  Effect of dietary fiber fermentation on short chain fatty acid production and microbial composition in vitro. , 2020, Journal of the science of food and agriculture.

[32]  Wei Hu,et al.  Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder. , 2020, Pharmacological research.

[33]  K. Śliżewska,et al.  The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome , 2020, Nutrients.

[34]  E. Chambers,et al.  Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function , 2020, Nature Metabolism.

[35]  I. Kimura,et al.  Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43 , 2020, Scientific Reports.

[36]  P. Sansonetti,et al.  Fermentation Products of Commensal Bacteria Alter Enterocyte Lipid Metabolism. , 2020, Cell host & microbe.

[37]  N. Chalasani,et al.  Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity , 2020, Hepatology.

[38]  Zhipeng Xu,et al.  Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro. , 2020, Life sciences.

[39]  R. Frozza,et al.  The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication , 2020, Frontiers in Endocrinology.

[40]  Zu-hua Gao,et al.  Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion , 2020, International journal of molecular sciences.

[41]  G. Pastore,et al.  Novel insights into prebiotic properties on human health: A review. , 2020, Food research international.

[42]  M. Vinolo,et al.  Effect of Short Chain Fatty Acids on Age-Related Disorders. , 2020, Advances in experimental medicine and biology.

[43]  M. Hagve,et al.  Perioperative infusion of glucagon like peptide-1 prevents insulin resistance after surgical trauma in female pigs. , 2019, Endocrinology.

[44]  C. Gazzaruso,et al.  The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases. , 2019, Current opinion in pharmacology.

[45]  M. Cheng,et al.  Gut microbial‐derived butyrate is inversely associated with IgE responses to allergens in childhood asthma , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[46]  J. Vendrell,et al.  Gut microbiota-derived succinate: Friend or foe in human metabolic diseases? , 2019, Reviews in Endocrine and Metabolic Disorders.

[47]  Yao Yao,et al.  Short Chain Fatty Acids and Fecal Microbiota Abundance in Humans with Obesity: A Systematic Review and Meta-Analysis , 2019, Nutrients.

[48]  E. Blaak,et al.  The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity , 2019, Nutrients.

[49]  Chang-liang Zhu,et al.  Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria , 2019, Critical reviews in food science and nutrition.

[50]  B. Vervliet,et al.  The role of short-chain fatty acids in microbiota–gut–brain communication , 2019, Nature Reviews Gastroenterology & Hepatology.

[51]  N. Gooderham,et al.  Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles , 2019, Acta Diabetologica.

[52]  M. McCarthy,et al.  Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases , 2019, Nature Genetics.

[53]  Pingchang Yang,et al.  Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder , 2019, Scientific Reports.

[54]  G. D. da Rocha,et al.  Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles , 2019, Scientific Reports.

[55]  Xiao Wang,et al.  Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes , 2018, Experimental and therapeutic medicine.

[56]  G. Frost,et al.  Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2 , 2018, Diabetes, obesity & metabolism.

[57]  J. Sierra,et al.  Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors , 2018, Nutrients.

[58]  E. Chambers,et al.  Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health , 2018, Current Nutrition Reports.

[59]  Yuhong Yang,et al.  Microbiome and butyrate production are altered in the gut of rats fed a glycated fish protein diet , 2018 .

[60]  J. Garssen,et al.  The Anti-inflammatory Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Stimulated Endothelial Cells via Activation of GPR41/43 and Inhibition of HDACs , 2018, Front. Pharmacol..

[61]  Chang H. Kim.  Microbiota or short-chain fatty acids: which regulates diabetes? , 2017, Cellular & Molecular Immunology.

[62]  M. Giera,et al.  GC-MS Analysis of Short-Chain Fatty Acids in Feces, Cecum Content, and Blood Samples. , 2018, Methods in molecular biology.

[63]  J. García-Mena,et al.  Gut microbiome production of short-chain fatty acids and obesity in children , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[64]  André Karch,et al.  Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data , 2017, mSystems.

[65]  I. Kimura,et al.  Gut microbial metabolite short-chain fatty acids and obesity , 2017, Bioscience of microbiota, food and health.

[66]  James L. Richards,et al.  Erratum: Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes , 2017, Nature Immunology.

[67]  E. Chambers,et al.  The diet‐derived short chain fatty acid propionate improves beta‐cell function in humans and stimulates insulin secretion from human islets in vitro , 2017, Diabetes, obesity & metabolism.

[68]  H. Flint,et al.  Formation of propionate and butyrate by the human colonic microbiota. , 2017, Environmental microbiology.

[69]  K. Qi,et al.  Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota , 2016, Scientific Reports.

[70]  Yu-cai Fu,et al.  Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells. , 2016, General and comparative endocrinology.

[71]  Nagendra Singh,et al.  Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. , 2016, Pharmacology & therapeutics.

[72]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[73]  E. Chambers,et al.  Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods123 , 2016, The American journal of clinical nutrition.

[74]  L. Drago,et al.  Persisting changes of intestinal microbiota after bowel lavage and colonoscopy , 2016, European journal of gastroenterology & hepatology.

[75]  H. Flint.  Gut microbial metabolites in health and disease , 2016, Gut microbes.

[76]  L. Wojtczak,et al.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective , 2016, Journal of Lipid Research.

[77]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[78]  A. Margolles,et al.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..

[79]  W. D. de Vos,et al.  Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal , 2015, Nature Communications.

[80]  Ellen E. Blaak,et al.  Short-chain fatty acids in control of body weight and insulin sensitivity , 2015, Nature Reviews Endocrinology.

[81]  A. Ichimura,et al.  Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation , 2015, Nutrients.

[82]  Barbara M. Bakker,et al.  Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation , 2015, Diabetes.

[83]  Stefan Offermanns,et al.  Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes , 2015, Nature Medicine.

[84]  Jimmy D Bell,et al.  Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults , 2014, Gut.

[85]  Chang H. Kim,et al.  Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation , 2014, Immune network.

[86]  F. Bäckhed,et al.  Microbial modulation of insulin sensitivity. , 2014, Cell metabolism.

[87]  D. Artis,et al.  Epigenomic regulation of host-microbiota interactions. , 2014, Trends in immunology.

[88]  H. Flint,et al.  ‘ Diet, gut microbiology and human health , 2015 .

[89]  Harry J. Flint,et al.  The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.

[90]  F. Montecucco,et al.  Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes , 2014, Mediators of inflammation.

[91]  Jimmy D Bell,et al.  The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity , 2014, Obesity.

[92]  Z. Cai,et al.  Pyruvate-Associated Acid Resistance in Bacteria , 2014, Applied and Environmental Microbiology.

[93]  J. Tiedje,et al.  Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data , 2014, mBio.

[94]  A. Haslberger,et al.  Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. , 2014, Gene.

[95]  H. Flint,et al.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota , 2014, The ISME Journal.

[96]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[97]  C. Mackay,et al.  The role of short-chain fatty acids in health and disease. , 2014, Advances in immunology.

[98]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[99]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[100]  G. Frost,et al.  Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study , 2013, Appetite.

[101]  H. Flint,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[102]  S. Bloom,et al.  Selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival. , 2012, Gastroenterology.

[103]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[104]  Takafumi Hara,et al.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) , 2011, Proceedings of the National Academy of Sciences.

[105]  M. Cawthorne,et al.  Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids , 2010, FEBS letters.

[106]  M. Camilleri,et al.  Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. , 2010, Gastroenterology.

[107]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[108]  S. Ragsdale.  Enzymology of the Wood–Ljungdahl Pathway of Acetogenesis , 2008, Annals of the New York Academy of Sciences.

[109]  H. Hayashi,et al.  Prevotella copri sp. nov. and Prevotella stercorea sp. nov., isolated from human faeces. , 2007, International journal of systematic and evolutionary microbiology.

[110]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[111]  G. Macfarlane,et al.  Regulation of short-chain fatty acid production , 2003, Proceedings of the Nutrition Society.

[112]  H. Flint,et al.  Acetate Utilization and Butyryl Coenzyme A (CoA):Acetate-CoA Transferase in Butyrate-Producing Bacteria from the Human Large Intestine , 2002, Applied and Environmental Microbiology.

[113]  H. Flint,et al.  Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut , 2000, Applied and Environmental Microbiology.

[114]  G. Macfarlane,et al.  Enumeration of amino acid fermenting bacteria in the human large intestine: effects of pH and starch on peptide metabolism and dissimilation of amino acids , 1998 .

[115]  G. Macfarlane,et al.  Dissimilatory amino Acid metabolism in human colonic bacteria. , 1997, Anaerobe.

[116]  P. Mortensen,et al.  Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. , 1996, Scandinavian journal of gastroenterology. Supplement.

[117]  H. A. Barker,et al.  Pathway of lysine degradation in Fusobacterium nucleatum , 1982, Journal of bacteriology.